John Dickson

Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial

Dilan Athauda, Kate Maclagan, Simon S. Skene et al. · The Lancet · 2017 · 851 citations · Full text

Medicine, Neurology, Pharmacology +12

Exenatide and the treatment of patients with Parkinson’s disease

Icíar Avilés-Olmos, John Dickson, Zinovia Kefalopoulou et al. · Journal of Clinical Investigation · 2013 · 514 citations

Medicine, Neurology, Pharmacology +17

Functional imaging of neuroendocrine tumors with combined PET/CT using ⁶⁸Ga‐DOTATATE (DOTA‐<scp>D</scp>Phe¹,Tyr³‐octreotate) and ¹⁸F‐FDG

Irfan Kayani, Jamshed Bomanji, Ashley M. Groves et al. · Cancer · 2008 · 466 citations · Full text

Medicine, Oncology, Radiology +17

Attenuation Correction Synthesis for Hybrid PET-MR Scanners: Application to Brain Studies

Ninon Burgos, M. Jorge Cardoso, Kris Thielemans et al. · IEEE Transactions on Medical Imaging · 2014 · 388 citations · Full text

Medicine, Nuclear Medicine, Radiology +17

Motor and Cognitive Advantages Persist 12 Months After Exenatide Exposure in Parkinson’s Disease

Icíar Avilés-Olmos, John Dickson, Zinovia Kefalopoulou et al. · Journal of Parkinson s Disease · 2014 · 295 citations · Full text

Medicine, Neurology, Pharmacology +14